Measurement of a novel serological marker for pancreatic cancer in esophageal, gastric, hepatic, bile duct and colorectal cancers
Not Applicable
Recruiting
- Conditions
- Esohageal cancer, gastric cancer, hapatic cancer, bile duct cancer, colorectal cancer
- Registration Number
- JPRN-UMIN000027906
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Kochi Medical School, Kochi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients who were suffering from any kind of malignancies (2) sever renal or liver dysfunction (3) individuals who did not accept informed consent (4) unsuitable individuals for this clinical study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the IGFP levels between patients of Esohageal, gastric, hapatic, bile duct, colorectal cancers and control individuals
- Secondary Outcome Measures
Name Time Method Comparison of the area under the curve (AUC) of Reciever Operating Characteristic Curves (ROC curves) between IGFP and CA19-9